Accelerate your science at Chiesi’s Pharma Day

Feb 29, 2024

A photo of a woman working a lab with the text Chiesi Pharma Day, May 29, 2024, 3:00 PM - 6:30 PM, MassBioHub and a yellow Register button.

MassBio is partnering with Chiesi on May 29, 2024, to host 2024 Chiesi Pharma Day. MassBio’s Pharma Days are unparalleled opportunities for emerging innovators to learn from and connect with world-leading biopharmaceutical companies. Chiesi Global Rare Diseases was founded in February 2020 and is based in Boston, established to deliver innovative therapies and solutions for people living with rare diseases. The company is working to ensure access to treatments, no matter how rare the condition, so as many people as possible can experience their most fulfilling life.

What they’re saying:

“We’re delighted to sponsor a Chiesi Pharma Day at MassBio and host Chiesi’s open information session, offering invaluable insights into the therapeutic modalities prioritized by the Strategic Innovation Unit, therapeutic areas of interest, and partnering opportunities.

We believe in fostering collaboration and innovation within the healthcare industry, which is why we invite innovators in gene editing, gene therapy, and nucleotide delivery technologies to join us. This event not only facilitates networking but also presents a unique opportunity for potential partnerships. Together, we can drive advancements in healthcare and positively impact patients’ lives. We look forward to connecting with like-minded individuals and exploring new possibilities for groundbreaking research and development.”

Fernando Tricta, Head of Strategic Innovation

Hear the latest: Join Chiesi’s open information session for the latest insights on its R&D strategy, target therapeutic areas, and partnering capabilities. A networking reception will follow this session.

  • Register now for the full information session, which includes a keynote address and panel discussion, and the closing reception.

Get closer: Innovators developing in vivo gene editing or in vivo gene therapy approaches, as well as nucleotide delivery technologies who are actively looking for partners, are encouraged to apply for a one-on-one meeting with Chiesi representatives. Chiesi’s target therapeutic areas within rare diseases are:

  • Hematology
  • Immunology
  • Dermatology
  • Ophthalmology
  • Endo-metabolic
  • Inborn errors of metabolism
  • Respiratory

If your company meets our eligibility guidelines, apply for a one-on-one meeting by March 15 at 11:59 AM ET.

See all MassBio News